“ We are working upon low cost & easily deployable diagnostic tools ”
In an exclusive interview , Subodh Gupta , Chief Executive Officer , Lord ’ s Mark Microbiotech shares details on the company ’ s long-term vision , its initiatives including genomic testing , and personalized healthcare
By Rahul Koul
What is the vision behind Lord ’ s Mark Microbiotech ? Key milestones achieved so far ?
With the launch of MyDNA through its subsidiary , Lords Mark Microbiotech , the Lords Mark Industries plans to foray into preventive as well as clinical genetic testing across the country . MyDNA is formed with prime focus to alleviate and improve the health of Indians by delivering personalized , actionable insights through genome testing . MyDNA not only addresses the unanswered questions regarding health , fitness and genetic disorders but also predicts the future and the risk to develop widespread genetic and lifestyle diseases . Innovation and technology upgradation will be the key focus area so as to provide the latest and accurate testing methodologies .
We have been able to offer eighth preventive genetic test to doctors and patients which encompass various therapy areas like cardiology , oncology , comprehensive genetic risk profiling , paediatrics , women health , dermatology , fitness and pharmacogenomics .
Can you elaborate on the specific areas within microbiology that the company specializes in and the potential impact of your work ?
In the area of Genome testing , it will be our endeavour to take this technology through our brand MyDNA to the
BioTech
BIOVOICENEWS . COM 43